Compare Claros Diagnostics vs MedShape
Customers evaluate the quality of Claros Diagnostics's products using the following success metrics.
Overview
Claros Diagnostics is 20 yrs old and is based in United States.
Claros Diagnostics is an early stage device company developing a POC multiplex diagnostic focused on a biomarker panel for prostate cancer.
MedShape is 19 yrs old and is based in United States.
MedShape is a medical device company working to develop and commercialize a portfolio of surgical solutions that use its shape memory technologies to address the increasing demand for improved sports medicine, joint fusion, and musculoskeletal trauma products. On April 26, 2021, MedShape was acquired by DJO. The terms of the transaction were not disclosed.
Demo Video
Leadership
Vincent Linder Ph.D. (Founder)
Jack Griffis (President, Senior Vice President)
Investors
Oxford Bioscience Partners, BioVentures Investors
DJO, U.S. Department of Defense
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Claros Diagnostics has not claimed their profile.
Work for Claros Diagnostics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Claros Diagnostics?
Claim your profile now.
Information not available because MedShape has not claimed their profile.
Work for MedShape? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for MedShape?
Claim your profile now.